From September 20, 2023 to September 30, 2023, the company has repurchased 2,908,980 shares, representing 0.26% for CNY 49.98 million. With this, the company has completed the repurchase of 2,908,980 shares, representing 0.26% for CNY 49.98 million under the buyback announced on September 21, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.85 CNY | -1.39% | -0.93% | -1.92% |
29/04 | Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
17/04 | Aodong Medicine's 2023 Profit Declines 18%; Revenue Up 20% | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-1.92% | 249.02Cr | |
+31.37% | 59TCr | |
-3.11% | 36TCr | |
+19.56% | 33TCr | |
+5.17% | 29TCr | |
+14.83% | 24TCr | |
+9.93% | 21TCr | |
-6.95% | 20TCr | |
+10.63% | 17TCr | |
+0.51% | 16TCr |
- Stock Market
- Equities
- 000623 Stock
- News Jilin Aodong Pharmaceutical Group Co., Ltd.
- Tranche Update on Jilin Aodong Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on September 21, 2023.